Release Date: 09/07/10 11:08 Summary: Chief Executive Officer Remuneration Package Price Sensitive: No Download Document 56.29KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%